Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort.

scientific article published in January 2017

Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/2047487317706585
P8608Fatcat IDrelease_t535fn7kajgddb5bynytw3frfu
P698PubMed publication ID28429955

P50authorMikko T NieminenQ43269029
Aki S HavulinnaQ57560665
Stefan BlankenbergQ28039327
Veikko SalomaaQ28050067
Tanja ZellerQ29840607
P2093author name stringTimo Sorsa
Taina Tervahartiala
Pirkko J Pussinen
Immi Kormi
P2860cites workSerum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men.Q43769669
Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammationQ44448828
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID studyQ46736337
Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activityQ47266111
Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart StudyQ47406734
Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based studyQ47960038
Plasma concentrations of myeloperoxidase predict mortality after myocardial infarctionQ48162839
Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound.Q48711796
Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.Q52664719
Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction.Q53664698
Practical implications of novel serum ELISA-assay for matrix metalloproteinase-8 in acute cardiac diagnosticsQ57315634
Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg studyQ57414500
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant dataQ28742740
Inflammation in atherosclerosisQ29547428
Heart disease and stroke statistics--2012 update: a report from the American Heart AssociationQ29547909
General cardiovascular risk profile for use in primary care: the Framingham Heart StudyQ29614189
Myeloperoxidase and its contributory role in inflammatory vascular disease.Q30352941
The validation of the Finnish Hospital Discharge Register and Causes of Death Register data on stroke diagnosesQ31115680
The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversityQ33786342
Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiographyQ34103514
Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortalityQ34222299
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaquesQ34327535
Genetic risk prediction and a 2-stage risk screening strategy for coronary heart diseaseQ34411343
Endotoxemia is associated with an increased risk of incident diabetesQ34507178
Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarctionQ34963719
Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacityQ35536038
Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition.Q36526033
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation.Q36580334
Do metalloproteinases destabilize vulnerable atherosclerotic plaques?Q36589031
Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.Q36805538
C-reactive protein, fibrinogen, and cardiovascular disease predictionQ37021409
Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysisQ37963722
Onset of mucosal, dermal, and general symptoms in relation to biomarkers and exposures in the dwelling: a cohort study from 1992 to 2002.Q38434905
Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C.Q39045940
Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population StudyQ40196845
Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in miceQ40224260
Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.Q40380481
Depression and Its Comorbid Conditions More Serious in Women than in Men in the United States.Q41624031
Geographic patterns of incidence of ischemic stroke and acute myocardial infarction in Finland during 1991-2003.Q42645598
Thirty-five-year trends in cardiovascular risk factors in FinlandQ43230334
P433issue11
P921main subjectcardiovascular diseaseQ389735
P304page(s)1136-1144
P577publication date2017-01-01
P1433published inEuropean Journal of Preventive CardiologyQ2493290
P1476titleMatrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort.
P478volume24

Reverse relations

cites work (P2860)
Q64071126Association of Circulating Tissue Inhibitor of Metalloproteinases-1 and Procollagen Type III Aminoterminal Peptide Levels With Incident Heart Failure and Chronic Kidney Disease
Q57156814Diagnosis of Newly Delivered Mothers for Periodontitis with a Novel Oral-Rinse aMMP-8 Point-of-Care Test in a Rural Malawian Population
Q97545917Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 - secondary analysis of a randomized controlled trial

Search more.